Drug Pipeline

YL202 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
2
Phase 3
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-27 NCT07461454
YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer		 Recruitment opened
Active Studies by Phase
Phase 3
2
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07461454 YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer Locally Advanced or Metastatic Breast Cancer Recruiting
NCT07416994 Pivotal Study to Evaluate YL202 Versus Docetaxel in Patients With Locally Advanced or… Non-Small Cell Lung Cancer Not Yet Recruiting
Phase 2
NCT07202364 A Study of YL202 in Patients With Advanced Solid Tumors Non Small Cell Lung Cancer Recruiting
Phase 1
NCT05653752 A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung… Non Small Cell Lung Cancer Active, Not Recruiting
Sponsors Running YL202 Trials
MediLink Therapeutics (Suzhou) Co., Ltd. (4)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (3) Lung Cancer (3) Breast Cancer (2) Colorectal Cancer (1) Cervical Cancer (1)
Get alerts when YL202 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free